ALTO NEUROSCIENCE INC (ANRO) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:ANRO - US02157Q1094 - Common Stock
13.39 USD
+0.59 (+4.61%)
13.39 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to ANRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 30.16. This target is 125.26% above the current price.
ANRO was analyzed by 15 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ANRO.
In the previous month the buy percentage consensus was at a similar level.
ANRO was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-17 | BTIG | Initiate | Buy |
| 2025-11-13 | Baird | Maintains | Outperform -> Outperform |
| 2025-11-12 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-20 | Baird | Maintains | Outperform -> Outperform |
| 2025-09-29 | Chardan Capital | Initiate | Buy |
| 2025-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-15 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-04-07 | HC Wainwright & Co. | Initiate | Buy |
| 2024-12-16 | Jones Trading | Initiate | Buy |
| 2024-11-13 | Stifel | Maintains | Buy -> Buy |
| 2024-10-23 | Wedbush | Downgrade | Outperform -> Neutral |
| 2024-10-23 | Baird | Maintains | Outperform -> Outperform |
| 2024-09-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-03 | Wedbush | Initiate | Outperform |
| 2024-06-21 | Rodman & Renshaw | Initiate | Buy |
| 2024-03-25 | Stifel | Reiterate | Buy -> Buy |
| 2024-02-27 | Stifel | Initiate | Buy |
| 2024-02-27 | Baird | Initiate | Outperform |
| 2024-02-27 | Jefferies | Initiate | Buy |
ALTO NEUROSCIENCE INC / ANRO FAQ
What is the average price target for ALTO NEUROSCIENCE INC (ANRO) stock?
15 analysts have analysed ANRO and the average price target is 30.16 USD. This implies a price increase of 125.26% is expected in the next year compared to the current price of 13.39.
How do analysts rate ALTO NEUROSCIENCE INC (ANRO)?
The consensus rating for ALTO NEUROSCIENCE INC (ANRO) is 85.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.